Trademarkia Logo

Canada

C$
Trademark Search in Canada
ASPIRA SYNERGY

View On IC.GC.CA

ASPIRA SYNERGY
ABANDONED SECTION 36

on 24 Jan 2023

Last Applicant/ Owned by

ASPIRA WOMEN'S HEALTH INC.

12117 Bee Caves Road Building III, Suite 100Austin TX 78738

US

Serial Number

2169885 filed on 28th Jul 2021

ASPIRA SYNERGY

Trademark usage description

providing on-line non-downloadable software for medical diagnostic testing in the fields of oncology, women's health, genetics, gynecology, ovarian ca Read More

Classification Information

Class [042]
Providing on-line non-downloadable software for medical diagnostic testing in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Providing on-line non-downloadable software for gynecological diagnostic testing; Providing on-line non-downloadable software for cancer diagnostic testing; Providing on-line non-downloadable software for genetic testing; Software as a service (SAAS) services featuring software for medical diagnostic testing; Software as a service (SAAS) services featuring software for gynecological diagnostic testing; Software as a service (SAAS) services featuring software for cancer diagnostic testing; Software as a service (SAAS) services featuring software for genetic testing; Software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; Consulting services in the field of software as a service (SAAS); Design and development of computer software for use in the healthcare field; Implementation and maintenance of computer software for use in fields of healthcare, oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; Providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; Providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; Providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing

Classification kind code

11

Class [044]
Medical testing for diagnostic or treatment purposes in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical information services, namely, reporting of consumer authorized clinical testing results for clinical review; providing medical information to doctors and patients in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; medical analysis services for the diagnosis of cancer; providing medical information, consultancy and advisory services in the fields of oncology, women's health, genetics, gynecology, ovarian cancer, breast cancer, endometriosis; DNA screening for medical purposes; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical diagnosis of endometriosis; genetic testing for medical purposes.

Classification kind code

11

Mark Details

Serial Number

2169885

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 256
on 3rd Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 14
on 1st Nov 2022		Default Notice Sent
Submitted for opposition 22
on 11th Apr 2022		Search Recorded
Submitted for opposition 20
on 11th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 11th Apr 2022		Total Provisional Refusal
Submitted for opposition 257
on 3rd Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 2th Mar 2022		Formalized
Submitted for opposition 1
on 2th Mar 2022		Created
Submitted for opposition 228
on 28th Jul 2021		International Registration
Submitted for opposition 30
on 28th Jul 2021		Filed